$Raffles Medical (BSL.SG)$ エグゼクティブチェアマンは、それぞれ8月1日と8月2日に1.18ドル（53,000株）と1.24ドル（300,000株）で株を購入しました。

$グラブ・ホールディングス (GRAB.US)$ As per Bernstein latest coverage, i think the current price present a good opportunity to get a piece with a limited downside. Can try some buy and sell range or accumulate some and hope for better results.

$Raffles Medical (BSL.SG)$ recent company share buy back (incl Director/CEO) indicates that the price is considerably cheap. The last time there are director/CEO buying was at 0.78 where the share prices went higher not too long after. Dividend is 2.8cents round the corner (2.5cents a year before)
Moverover, with Covid-19still here to stay for some time. Profitability should not be an issue.

$グラブ・ホールディングス (GRAB.US)$ With institutional buy Temasek and MSCI inclusion, Grab should have a boost till at least 3 March when they release their result. Make it or break it then...

$フートゥー・ホールディングス (FUTU.US)$希望に満ちた